Pulmonary Embolism

San Rafael, CA US
March 21, 2017

Planning Committee: 

 

Sridhar Prasad, M.D., Pulmonary/Critical Care, CME Chief, KP San Rafael

Target Audience

Primary care and HBS physicians.

Learning Objectives

1. Discuss the risks and benefits of TSOA vs warfarin.
2. Correctly suspect and identify chronic thromboembolic pulmonary hypertension (CTEPH).
3. Discuss indefinite anticoagulation vs temporary anticoagulation.
4. Identify the risks and benefits of catheter directed thrombolysis (CDT).
5. List the risks and benefits of withholding anticoagulation in select patients.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 0.00 Attendance
Course opens: 
03/21/2017
Course expires: 
03/21/2017
Event starts: 
03/21/2017 - 12:30pm
Event ends: 
03/21/2017 - 1:30pm
Rating: 
0
Kaiser Permanente San Rafael
99 Montecillo Road
MOB 2 Rooms 1&2
San Rafael, CA 94903
United States
Faculty:

Sridhar Prasad, M.D., Pulmonary/Critical Care, CME Chief, KP San Rafael

 

Statement of Disclosure: 

Kaiser Permanente Medical Center – San Rafael has determined that the speaker(s) and the planning committee (including the KP San Rafael CME Committee) for this activity do not have any relevant financial relationships. Kaiser Permanente Medical Center – San Rafael takes responsibility for the content, quality, and scientific integrity of this CME activity.

 

Accreditation and Credit Designation statements: 

The Kaiser Permanente Medical Center – San Rafael is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.


The Kaiser Permanente Medical Center – San Rafael designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 0.00 Attendance
Please login or register to take this course.